[Pharmacological and clinical aspects of the use of a new choleretic, 1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride].
D000328:Adult; D001646:Bile / Q000378:metabolism; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D005243:Feces / Q000032:analysis; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*
D002756:Cholagogues and Choleretics; D011799:Quinazolines
Aspetti farmacologici e clinici connessi all'impiego di un nuovo coleretico, l'1-morfolinoacetik-3-fenil-4-oxo-1,2,3,4-tetraidrochinazolina cloridrato.